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Abstract
Background
Trends towards day case surgery and enhanced recovery mean that postoperative venous
thromboembolism (VTE) may increasingly arise after hospital discharge. However, hospital
data alone are unable to capture adverse events that occur outside of the hospital setting.
The National Institute for Health and Care Excellence has suggested the use of primary
care data to quantify hospital care-related VTE. Data in surgical patients using these
resources is lacking. The aim of this study was to measure VTE risk and associated mortal-
ity in general surgery using linked primary care and hospital databases, to improve our
understanding of harm from VTE that arises beyond hospital stay.
Methods
This was a longitudinal cohort study using nationally linked primary care (Clinical Practice
Research Datalink, CPRD), hospital administrative (Hospital Episodes Statistics, HES),
population statistics (Office of National Statistics, ONS) and National Cancer Intelligence
Network databases. Routinely collected information was used to quantify 90-day in-hospital
VTE, 90-day post-discharge VTE and 90-day mortality in adults undergoing one of twelve
general surgical procedures between 1st April 1997 and 31st March 2012. The earliest post-
operative recording of deep vein thrombosis or pulmonary embolism in CPRD, HES and
ONS was counted in each patient. Covariates from multiple datasets were combined to
derive detailed prediction models for VTE and mortality. Limitation included the capture of
VTE presenting to healthcare only and the lack of information on adherence to pharmaco-
logical thromboprophylaxis as there was no data linkage to hospital pharmacy records.
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Results
There were 981 VTE events captured within 90 days of surgery in 168005 procedures
(23.7/1000 patient-years). Overall, primary care data increased the detection of postopera-
tive VTE by a factor of 1.38 (981/710) when compared with using HES and ONS only. Total
VTE rates ranged between 3.2/1000 patient-years in haemorrhoidectomy to 118.3/1000
patient-years in esophagogastric resection. Predictors of VTE included emergency surgery
(OR = 1.91 95%CI 1.60–2.28, p<0.001), age (OR = 1.02 95%CI 1.02–1.03, p<0.001), body
mass index (OR = 1.03 95%CI 1.01–1.04, p<0.001), previous VTE (OR = 8.07 95%CI 6.61–
9.83, p<0.001), length of stay (OR = 1.00 95%CI 1.00–1.00, p = 0.007) and cancer stages II
(OR = 1.38 95%CI 1.03–1.87, p = 0.033), III (OR = 1.50 95%CI 1.11–2.01, p = 0.008) and IV
(OR = 1.63 95%CI 1.03–2.59, p = 0.038). Major organ resections had the greatest odds of
VTE when adjusted for other risk factors including length of hospital stay. Post-discharge
VTE accounted for 64.8% (636/981) of all recorded VTE. In-hospital VTE (165.4/1000
patient-years) was recorded more frequently than post-discharge VTE (16.2/1000 patient-
years). Both in-hospital (OR = 2.07 95%CI 1.51–2.85, p<0.001) and post-discharge (OR =
4.03 95%CI 2.95–5.51, p<0.001) VTE independently predicted 90-day mortality. In patients
who died and VTE was recorded on HES or CPRD (n = 56), VTE was one of the causes of
death in 37.5% (21/56) of cases.
Conclusions
A large proportion of postoperative VTE was detected in primary care. Evaluation of linked
databases was a useful way of measuring postoperative VTE at population level. These
resources identified a significant association between post-discharge VTE and mortality in
general surgery.
Introduction
Postoperative venous thromboembolism (VTE) can have devastating effects on patients. How-
ever, VTE rates are difficult to estimate at population-level. In surgery, increasing trends
towards day case operating, enhanced recovery and early discharge mean that a significant pro-
portion of VTE may present after hospital discharge and be treated in the ambulatory setting.
[1, 2]Previous studies report that VTE risk persists up to 90 days after surgery and beyond hos-
pital stay.[3, 4] The National Institute for Health and Care Excellence (NICE) suggest the need
to scrutinize primary care data to gain a complete picture of postoperative VTE at a population
level and shape future thromboprophylaxis policy.[5] Primary care physicians in the United
Kingdom (UK) are well placed to observe post-discharge adverse events as they are often the
first point of contact for patients in this scenario.[6]
Studies evaluating Hospital Episodes Statistics (HES), an administrative hospital database in
England, have estimated postoperative VTE rates in some surgical procedures.[7–9] However,
HES by itself is limited to capturing in-hospital adverse events and those recorded during read-
mission. Linkage to primary care electronic health records allows for a multisource perspective
of patients’ entire health journeys. Linked databases offer patient-level information by combin-
ing hospital administrative, primary care, population statistics and cancer registry databases.
These resources have previously been used to quantify the risk of post-discharge VTE in
patients with colorectal cancer and in hospitalized pregnant women.[10, 11] Whether linked
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data can evaluate postoperative VTE rates across different surgical procedures in patients with
varying degrees of VTE risk has not previously been assessed.
Thromboprophylaxis guidelines in the UK have originated from the THRIFT (Thrombo-
embolic Risk Factors Consensus Group) recommendations, which were derived from in-
patient data.[12] More recently, the importance of outpatient thromboprophylaxis to prevent
post-discharge VTE in major cancer resection has been recognized.[13] The current NICE
guidelines recommend that general surgical patients receive either no thromboprophylaxis, in-
patient thromboprophylaxis or thromboprophylaxis to 28 days after surgery based on defined
VTE risk criteria.[5] Analysis of linked hospital and primary care data may improve our under-
standing of post-discharge VTE risk and help develop future policy for outpatient
thromboprophylaxis.
This study aims to measure postoperative VTE and associated mortality up to 90 days fol-
lowing general surgical procedures using linked hospital and primary care databases in
England. The study evaluates surgical VTE risk, particularly that which continues in the outpa-
tient setting, to explore whether these resources can increase our knowledge about surgical
harm from a primary care perspective.
Methods
Database Linkage
The UK has one of the largest numbers of electronic primary care health records in the world
that can help evaluate the quality of care provided by the National Health Service (NHS).[14]
The Clinical Practice Research Datalink (CPRD), formerly the General Practice Research Data-
base, has generated the highest number of peer-reviewed publications from primary care data
of any such database globally.[15] Other databases in the UK include The Health Improvement
Network, Secure Anonymized Information Linkage System and Egerton Medical Information
System, which offer fewer patients with linkage to other databases compared with CPRD. In
CPRD, over 600 primary care practices covering 8.5% of the UK population are registered to
use the Vision software for recording information during consultations. Anonymized patient
information is automatically uploaded to CPRD with an ‘opt-out’ clause for patients in con-
senting practices. About 50% of CPRD practices are linked to in-patient HES data, which con-
tain procedural and diagnostic information for each episode of hospital care in England.
Additionally, 95% of HES-linked practices also have Office of National Statistics (ONS) linkage
to death certificates that contain codes for causes of death. Only practices with HES and ONS
linkage were included in the study. CPRD also offer linkages to clinical registries. Out of these,
the National Cancer Intelligence Network (NCIN) database was relevant to this study. In
patients with CPRD, HES and ONS linkage, 90% of cancer patients were linked to NCIN.
Patient linkage was performed centrally using the NHS number.[16] Database coverage was for
index procedures performed between 1st April 1997 and 31st March 2012 with at least 90 days
follow-up (to 30th June 2012) in all databases.
Study Population
Surgical patients and indications for surgery were identified from the HES database as the accu-
racy of operative and diagnostic coding has previously been validated.[17] Patients undergoing
one of twelve index general surgical procedures coded in HES using the Classification of Inter-
ventions and Procedures from the Office of Population Census and Surveys (OPCS) version
4.4 and the International Classification of Diseases version 10 (ICD-10) (S1 Table) were
included. These procedures represent the majority of emergency and elective general surgical
operations in UK hospitals. Patients were included in the analysis if they were coded for an
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index procedure by a primary (in the first position of an episode of care) OPCS code for the
first chronological operation during hospital admission. Only those patients in whom the
index episode also specified a designated diagnosis (coded in the first position for diagnostic
code by ICD-10) as the indication for surgery were included in the study. Only adults aged 18
or over were eligible. Patients were included if they met the up-to-standard criteria for data
quality set by CPRD. These criteria incorporated patient and practice level parameters that fil-
tered out poor quality data by identifying discrepancies in coding and periods of missing
information.
Venous Thromboembolism Rate
VTE events were counted to calculate 30, 60 and 90-day VTE rates by combining data from
CPRD, HES and ONS using diagnostic codes for deep vein thrombosis (DVT) and pulmonary
embolism (PE) (S2 Table). In CPRD, medcodes are mapped equivalents of the widely used
READ clinical coding system in primary care in the UK. Codes for VTE in CPRD have been
reported previously.[18] Validation against hospital correspondence and physician question-
naires found them to be 84% accurate.[19] In CPRD, VTE was defined as a code for DVT or
PE with evidence of anticoagulation between 15 days before and 90 days after the event, or
death within 30 days of the event as previously described.[11, 19, 20] ICD-10 codes were used
to identify DVT and PE in HES and ONS. In HES, VTE was recorded if it was coded during
the index hospital admission (any diagnostic code except for the diagnostic code in the first
position of the index episode) or if it was the reason for hospital readmission (first diagnostic
code in an episode of readmission) within 90 days of surgery. In ONS, a VTE event was
counted if it was recorded in a death certificate and death occurred within 90 days of surgery.
Only the earliest recording of VTE after surgery in any database was counted in each patient.
Short-term VTE rates were calculated for the most commonly performed procedures to allow
for comparisons with studies that report VTE rates but have shorter follow-up.
Venous Thrombolism Risk
Multiple regression analysis for postoperative VTE was performed by entering risk factors out-
lined in the NICE thromboprophylaxis guidelines.[5] In addition, cancer stage was incorpo-
rated into the model in light of growing recognition of cancer-specific variables in predicting
surgical outcome.[21] Year of surgery was also included to assess whether there were any asso-
ciations over time. The covariates used to evaluate VTE risk together with the corresponding
databases from which they were derived from are listed below:
1. age (all databases)
2. gender (all databases)
3. previous VTE (CPRD and HES)
4. body mass index (BMI) (CPRD)
5. comorbidity (HES)
6. emergency surgery (HES)
7. length of stay (HES)
8. year of surgery (HES)
9. index surgical procedure (HES)
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10. cancer stage (NCIN)
11. oral contraceptive pill (OCP) (CPRD)
12. hormone replacement therapy (HRT) (CPRD)
Cancer stage was categorized according to the TNM classification system with stage group-
ing I-IV.[22] Previous VTE was determined by identifying VTE codes in HES and CPRD
before surgery. ICD-10 codes for fifteen different comorbidities (excluding malignancy and
metastases) were adopted from a previous study.[23] The presence of one or more comorbidi-
ties was evaluated against VTE risk in accordance with the risk assessment method described
in the guidelines. The use of OCP and HRT were defined as a prescription for British National
Formulary codes 7.3.1, 7.3.2, 13.6.2 and 6.4.1.1 within three months before surgery, as previ-
ously described.[18]
In-Hospital and Post-Discharge Venous Thromboembolism
Whether VTE was recorded before or after hospital discharge was determined from the dis-
charge date of the index hospital admission in HES. Post-discharge VTE was defined as those
recorded in CPRD or ONS after the discharge date of the index admission, or those leading to
hospital readmission after this date in HES. The remaining VTE events recorded in the index
admission in HES or before the index discharge date in CPRD and ONS were classified as in-
hospital VTE.
Mortality
Death, date of death and cause of death were defined from ONS data. Multiple regression
analysis explored the risk-adjusted effects of in-hospital and post-discharge VTE on mortality
separately. To assess whether VTE recorded in CPRD and HES contributed to death, death cer-
tificates were evaluated after excluding patients with VTE recorded in ONS data only. VTE-
related death was defined as death with recorded VTE in either CPRD or HES databases and
VTE recorded as one of the causes of death. As VTE was always recorded before or at the time
of death in this context, VTE was considered to cause or contribute to death these patients.
Statistical Analysis
SPSS version 22.0 (SPSS for Windows, Chicago, Illinois) was used for all analyses. For logistic
regression analysis all variables were entered into the model from the outset. Age, length of
stay and BMI were treated as continuous variables. All other variables were categorical. For the
analysis of VTE risk, gender and hormone treatment were combined in a single categorical var-
iable. A p<0.05 was statistically significant for all tests.
Missing Data
Only recordings within five years before surgery were used to estimate preoperative BMI. Only
BMI recordings of 12–75 were considered valid to exclude out-lying values. Multiple imputa-
tion of missing values modeled BMI against age, sex, socioeconomic status and diabetes. Miss-
ing data from the NCIN database were handled by categorizing patients as unknown cancer
stage.
Results
Data from 353 practices with patient-level linkage of CPRD, HES, ONS and NCIN were stud-
ied. From 1st April 1997 to 31st March 2012, 168005 primary surgical procedures were
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evaluated in 159039 patients. Patient characteristics and mortality for the twelve different pro-
cedures are presented in Table 1. The mean time from preoperative recording of BMI to sur-
gery was 1.4 years. The proportion of patients with recorded BMI within five years before
surgery ranged from 55.1% to 71.4%, except for in bariatric surgery where 95.1% of patients
had these data. Previous history of VTE was recorded in 1.32% (2222/168005) of patients. Can-
cer stage data were available in 58.5% (23645/40452) of patients with malignancy. The avail-
ability of cancer stage data was highest (80.1%) in colorectal cancer resection (11629/14521)
and lowest (9.5%) in small bowel resection (19/200).
Venous Thromboembolism Rate
Different datasets recorded VTE at different rates over time (Fig 1). Overall, CPRD recorded
56.0% (549/981), HES recorded 66.3% (650/981) and ONS recorded 8.3% (81/981) of all
recorded VTE events. VTE was recorded in CPRD alone and not in any other database in
23.8% (136/571), 25.6% (207/810) and 27.6% (271/981) of VTE at 30, 60 and 90 days respec-
tively. Some VTE events were recorded in more than one database (Fig 2). When VTE was
recorded in two databases in the same patient, the overlap between CPRD and HES was 28.3%
(278/981) and HES and ONS was 2.1% (21/981). Compared with using HES and ONS without
CPRD, primary care data increased the detection of postoperative VTE by a factor of 1.38
(981/710).
When combining information from different databases, postoperative VTE was recorded in
571 (0.34%), 810 (0.48%) and 981 (0.58%) procedures at 30, 60 and 90 days respectively. Thirty-
day VTE rates for the four most commonly performed procedures were 1.26% (238/18923),
0.22% (47/21383), 0.13% (60/46303) and 0.17% (56/32164) for colorectal resection, breast exci-
sion, inguinal hernia repair and laparoscopic cholecystectomy respectively. Ninety-day VTE
rates ranged from 0.08% (14/17554) following haemorrhoidectomy to 2.92% (61/2091) following
esophagogastric resection (Table 2). PE was recorded more frequently than DVT in all three
databases. CPRD recorded the largest proportion of DVTs. There were 285, 398 and 75 PEs, and
Table 1. Characteristics and 90-daymortality for patients undergoing general surgical procedures between 1 April 1997 and 31 March 2012.
Patients Malignancy Age Gender BMI Mortality
Procedure
n n (%) Median (IQR) female (%) mean n (%)
Antireﬂux surgery 1219 0 (0) 47 (38–57) 545 (44.7) 27.8 2 (0.16)
Appendicectomy 13216 0 (0) 36 (24–49) 6099 (46.1) 26.5 42 (0.32)
Bariatric surgery 1475 0 (0) 44 (37–52) 1148 (77.8) 48.1 4 (0.27)
Breast excision 21383 21383 (100) 61 (51–70) 21383 (100) 27.2 100 (0.47)
Cholecystectomy 36197 0 (0) 53 (40–65) 27330 (75.5) 28.9 139 (0.38)
Colorectal resection 18923 14521 (76.7) 69 (59–77) 8964 (47.4) 26.6 1360 (7.19)
Haemorrhoidectomy 17554 0 (0) 52 (42–64) 8190 (46.7) 26.9 37 (0.21)
Hepatopancreatobiliary resection 1486 1486 (100) 65 (57–72) 650 (43.7) 26.7 80 (5.38)
Inguinal hernia repair 46303 0 (0) 62 (49–72) 3357 (7.3) 25.8 222 (0.48)
Esophagogastric resection 2091 2091 (100) 68 (59–74) 599 (28.6) 26.4 171 (8.18)
Small bowel resection 1727 200 (11.6) 65 (48–76) 990 (57.3) 25.6 229 (13.3)
Thyroid/parathyroid excision 6431 771 (12.0) 52 (40–64) 5205 (80.9) 27.0 40 (0.62)
Total 168005 40452 (24.1) 58 (44–69) 84460 (50.27) 27.4 2426 (1.44)
IQR = Interquartile range
BMI = body mass index
doi:10.1371/journal.pone.0145759.t001
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283, 255 and 34 DVTs recorded in CPRD, HES and ONS respectively. Only in 5.6% (55/981) of
procedures were both DVT and PE recorded in the same patient. Of these, DVT was recorded
chronologically before PE in 56.4%(31/55) of patients while DVT was recorded on the same day
as PE in 14.5% (8/55) of patients.
Venous Thromboembolism Risk
Regression analysis identified emergency surgery (OR = 1.91 95% CI 1.60–2.28, p<0.001), age
(OR = 1.02 95%CI 1.02–1.03, p<0.001), BMI (OR = 1.03 95%CI 1.01–1.04, p = 0.001), previous
history of VTE (OR = 8.07 95%CI 6.61–9.83, p<0.001), length of hospital stay (OR = 1.00 95%
CI 1.00–1.00, p = 0.007), stage II cancer (OR = 1.38 95%CI 1.03–1.87, p = 0.033), stage III can-
cer (OR = 1.50 95%CI 1.11–2.01, p = 0.008) and stage IV cancer (OR = 1.63 95%CI 1.03–2.59,
p = 0.038) as independent predictors of postoperative VTE (Table 3). Major organ resections
(colorectal resection, small bowel resection, hepatopancreatobiliary resection, esophagogastric
resection) were associated with the highest odds for VTE when adjusted for other covariates.
While BMI was an independent risk factor for VTE, bariatric surgery per se was associated
with a low risk of VTE when adjusted for predictor covariates including BMI.
In-Hospital and Post-Discharge Venous Thromboembolism
In-hospital VTE accounted for 35.2% (345/981) and post-discharge VTE accounted for 64.8%
(636/981) of all recorded VTE (Table 4). The proportion of post-discharge VTE out of all VTE
Fig 1. Cumulative postoperative VTE according to recorded database in general surgical procedures performed between 1 April 1997 and 31
March 2012.
doi:10.1371/journal.pone.0145759.g001
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events ranged from 31.8% to 88.4% according to surgical procedure. HES recorded 86.4% (298/
345) of all in-hospital VTE (VTE recorded during the index hospital admission) while CPRD
recorded 71.7% (456/636) of all post-discharge VTE (recorded after the discharge date). The
overall VTE rate was 23.7 per 1000 patient years. When taking into account the length of hos-
pital stay in each patient, the frequency of in-hospital VTE was 165.4 per 1000 patient years
while the frequency of post-discharge VTE was 16.2 per 1000 patient years.
Mortality
There were 2426 deaths up to 90 days after surgery irrespective of whether VTE was the cause of
death. Mortality in patients with recorded VTE was 11.8% (116/981). Over half of the deaths in
patients with recorded VTE occurred after hospital discharge (51.7%— 60/116). Regression anal-
ysis revealed that both in-hospital (OR = 2.07 95%CI 1.51–2.85, p<0.001) and post-discharge
VTE (OR = 4.03 95%CI 2.95–5.51, p<0.001) were independent predictors of mortality. Post-dis-
charge VTE was associated with higher odds of death than in-hospital VTE. For the remaining
covariates, emergency surgery, male gender, length of stay and cancer stage IV independently
predicted 90-day mortality (Table 5). In those patients who died and in whom a VTE event was
recorded on HES or CPRD (n = 56), VTE was recorded as one of the causes of death in 37.5%
(21/56) of patients. In these VTE-related deaths, death was at least partly caused by VTE.
Discussion
Principal Findings of Study
Patient-level linkage to CPRD helped identify more VTE events compared with using HES and
ONS only. CPRD increased detection of VTE by almost 40%. Combining databases helped
Fig 2. Venn diagram of VTE events according to recorded database showing overlap between databases in general surgical procedures
performed between 1 April 1997 and 31 March 2012.
doi:10.1371/journal.pone.0145759.g002
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reveal similar VTE rates as reported from the National Surgical Quality Improvement Program
(NSQIP), a dedicated registry for surgical adverse events.[2, 24–26] The highest rates were
observed amongst in-patients (76.4 to 288.9 per 1000 patient years) but VTE was also detected
after hospital discharge (2.6 to 82.1 per1000 patient years). As there was little overlap between
HES and CPRD, VTE is either being treated entirely in the outpatient setting or not being
recorded by hospitals and subsequently captured in primary care. Predictors of VTE included
patient factors such as age, BMI, history of VTE and moderate to advanced cancer stage, as
well as surgical factors such as emergency surgery and prolonged length of stay. Post-discharge
VTE was associated with significant increases in mortality (OR = 4.03) when modeled against
other predictors of death. Although inferences on causality cannot be made, a high proportion
of VTE were also recorded in death certificates when recorded in HES and CPRD. Overall, the
present analysis revealed significant harm from VTE in general surgery identified in the pri-
mary care setting, highlighting areas where refinement in policy may benefit patients.
Strengths andWeaknesses of Study
Surgical VTE rates were calculated using routinely collected population data, which requires
less resources and allows for longer durations of follow-up compared with prospective national
registries.[27] Follow-up in NSQIP is performed through case notes review and limited to
30 days after surgery. Combining routine databases may be a reliable way of gaining insights
into population-level outcomes and complimenting the results from prospective analyses. The
inclusion codes and definition of VTE used in this study were specific.[19, 20] Such a narrow
definition was chosen as this methodology has been previously validated but this may lead to
Table 2. VTE captured at 30, 60 and 90 days according to recorded database in general surgical procedures performed between 1 April 1997 and
31 March 2012.
Procedure Number of
patients
30
day
30
day
30
day
60
day
60
day
60
day
90
day
90
day
90
day
Overall rate n
(%)
CPRD HES ONS CPRD HES ONS CPRD HES ONS
Antireﬂux surgery 1219 4 1 0 1 3 0 0 0 0 7 (0.57)
Appendicectomy 13216 27 37 * 14 7 0 4 1 0 65 (0.49)
Bariatric surgery 1475 2 1 0 1 1 0 0 0 0 4 (0.27)
Breast excision 21383 28 27 * 29 16 * 25 16 * 118 (0.55)
Cholecystectomy 36197 31 56 * 13 15 0 17 7 0 109 (0.30)
Colorectal resection 18923 90 182 19 69 65 14 46 38 6 400 (2.11)
Haemorrhoidectomy 17554 3 3 * 3 2 0 0 2 * 14 (0.08)
Hepatopancreatobiliary
resection
1486 5 10 * 6 4 0 6 8 * 31 (2.09)
Inguinal hernia repair 46303 35 39 * 21 16 * 17 9 * 112 (0.24)
Esophagogastric resection 2091 9 27 * 9 6 * 5 5 * 61 (2.92)
Small bowel resection 1727 7 20 * 8 11 * 3 5 0 44 (2.55)
Thyroid/parathyroid excision 6431 9 9 0 0 0 0 2 1 * 16 (0.25)
Total 168005 250 412 36 174 146 28 125 92 17 981 (0.58)
CPRD = Clinical Practice Research Datalink
HES = Hospital Episodes Statistics
ONS = Ofﬁce of National Statistics
The overall rate of VTE captured by all databases exceeds the sum of number of VTE events in each database due to overlap of VTE recording between
databases
* Restricted disclosure in accordance with the Health and Social Care Information Centre small numbers policy
doi:10.1371/journal.pone.0145759.t002
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undercounting of VTE events. On HES data there is no present on arrival flag. Therefore, when
evaluating patients readmitted to hospital, only a VTE code in the primary diagnosis category
was included. VTE codes for PE and DVT were included, while codes for superficial phlebitis
and portal vein thrombosis were excluded.[4, 18] VTE derived from CPRD was considered valid
if there was evidence of anticoagulation.[19] For the purposes of risk stratification, linked data-
bases offered high numbers of patients and covariates that helped develop a detailed model for
VTE risk. Through the provision of highly granular information on a large scale, linked routine
data may serve as the foundation for individualizing prophylaxis strategies in the future.
Table 3. Multiple logistic regression analysis for 90-day VTE for patients undergoing general surgical procedures between 1 April 1997 and 31
March 2012.
Dependent factor = 90-day VTE Odds ratio (95% CI) Signiﬁcance
Emergency surgery 1.91 (1.60–2.28) p<0.001
Age 1.02 (1.02–1.03) p<0.001
BMI 1.03 (1.01–1.04) p = 0.001
Comorbidity 1.16 (1.00–1.35) p = 0.051
Year of surgery 0.99 (0.97–1.00) p = 0.127
Previous VTE 8.07 (6.61–9.83) p<0.001
Length of stay 1.00 (1.00–1.00) p = 0.007
SURGICAL PROCEDURE
Haemorrhoidectomy Reference
Bariatric surgery 2.32 (0.73–7.38) p = 0.156
Inguinal hernia repair 2.73 (1.56–4.77) p<0.001
Thyroid /parathyroid excision 3.14 (1.57–6.27) p = 0.002
Cholecystectomy 3.41 (1.95–5.96) p<0.001
Breast excision 4.39 (2.37–8.11) p<0.001
Appendicectomy 4.80 (3.53–6.52) p<0.001
Antireﬂux surgery 8.38 (5.26–13.35) p<0.001
Colorectal resection 11.28 (6.31–20.20) p<0.001
Small bowel resection 12.81 (6.85–24.00) p<0.001
Hepatopancreatobiliary resection 15.03 (7.37–30.64) p<0.001
Esophagogastric resection 17.24 (9.03–32.94) p<0.001
CANCER STAGE
No cancer Reference
Cancer stage I 1.26 (0.89–1.79) p = 0.200
Cancer stage II 1.38 (1.03–1.87) p = 0.033
Cancer stage III 1.50 (1.11–2.01) p = 0.008
Cancer stage IV 1.63 (1.03–2.59) p = 0.038
Cancer stage unknown 1.33 (0.99–1.79) p = 0.060
GENDER AND HORMONE THERAPY
Women < 45 years no OCP Reference
Women <45 years with OCP 1.86 (0.90–3.84) p = 0.094
Women >45 years no HRT 1.48 (1.03–2.13) p = 0.035
Women >45 years with HRT 1.48 (0.86–2.55) p = 0.158
All men 1.44 (1.00–2.06) p = 0.048
BMI = body mass index
VTE = venous thromboembolism
OCP = oral contraceptive pill
HRT = hormone replacement therapy
doi:10.1371/journal.pone.0145759.t003
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This study identified harm that presented to healthcare. The derived incidence of VTE was
therefore lower than in prospective studies with clinical follow-up or assessment by imaging.
[28] As harm presenting to healthcare may vary considerably, data-driven research must take
into account the type of health system from which the data is being generated. Another limita-
tion of the study is the lack of information on pharmacological thromboprophylaxis making
direct comparison of prescription data with CPRD challenging. Hospital pharmacy data were
not present on HES, therefore it was not possible to determine adherence to thromboprophy-
laxis guidelines. Further linkage to hospital pharmacy records would clarify whether guidelines
are being followed.
Comparison with Previous Studies
Population-based studies using HES and ONS suggested that the incidence of VTE is increased
up to 90 days after in-patient surgery (31.2 per 1000 patient years) and day-case surgery (4.8
per 1000 patient years).[4] Higher rates were observed in our study through the addition of pri-
mary care data. A significant number (51.7%) of deaths with a recording of VTE in at least one
database occurred after hospital discharge. Lester and colleagues evaluated hospital admissions
using HES and ONS and found that 37.6% (625/1661) of VTE-related deaths were post-dis-
charge.[29] The higher rate in the present study highlights the importance of this mechanism
of harm in general surgery. Other authors have used linked hospital and primary care data to
derive disease-specific VTE rates in the primary care population.[11, 30, 31] Walker et al
reported incidences of 13.9 per 1000 patient years in cancer and 3.0 per 1000 patient years in
Table 4. Length of hospital stay and rate of in-hospital and post-discharge VTE for patients undergoing general surgical procedures between 1
April 1997 and 31 March 2012.
Procedure Median
length of
stay (IQR)
Total
VTE
Total VTE In-
hospital
VTE
In-hospital
VTE
In-hospital
VTE
Post-
discharge
VTE
Post-
discharge
VTE
Post-
discharge
VTE
Number
of events
Rate per
1000
patient
years
Number
of events
Rate per
1000
patient
years
Proportion
of VTE %
Number of
events
Rate per
1000 patient
years
Proportion
of VTE %
Antireﬂux surgery 2 (1–4) 7 23.3 1 91.9 14.3 6 20.7 85.7
Appendicectomy 3 (2–5) 65 19.9 24 154.1 36.9 41 13.2 63.1
Bariatric surgery 2 (1–4) 4 11.0 1 76.4 25.0 3 8.6 75.0
Breast excision 3 (1–5) 118 22.4 17 77.6 14.4 101 20.0 85.6
Cholecystectomy 2 (1–3) 109 12.2 32 102.9 29.4 77 8.9 70.6
Colorectal resection 12 (8–18) 400 85.7 178 207.9 44.5 222 58.3 55.5
Haemorrhoidectomy 0 (0–1) 14 3.2 3 85.2 21.4 11 2.6 78.6
Hepatopancreatobiliary
resection
11 (8–18) 31 84.6 11 168.0 35.5 20 66.5 64.5
Inguinal hernia repair 0 (0–1) 112 9.8 13 90.5 11.6 99 8.8 88.4
Esophagogastric
resection
15 (11–
21)
61 118.3 28 246.6 45.9 33 82.1 54.1
Small bowel resection 14 (9–24) 44 103.3 30 288.9 68.2 14 43.5 31.8
Thyroid/parathyroid
excision
2 (1–4) 16 10.1 7 119.7 43.8 9 5.9 56.3
Total 2 (0–5) 981 23.7 345 165.4 35.2 636 16.2 64.8
IQR = interquartile range
VTE = venous thromboembolism
doi:10.1371/journal.pone.0145759.t004
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non-cancer populations.[20] The higher VTE rates in our study reflect the impact of surgical
intervention on patients. In another study using the same linked dataset, the postoperative
VTE rate for 4963 colorectal cancer resections was found to be 45.1 per 1000 patient years.[11]
The lower rate in this study compared with our results may have arisen from differences in
cohort selection and analytical methods. In our study, all HES-recorded VTE were included
regardless of whether patients had prescription data for anticoagulation. There may also have
been differences in codes used to identify VTE. Codes used in previous studies were not pub-
lished so it was not possible to determine whether they were the same as in our study.[11, 20]
In terms of routinely collected data from abroad, hospital administrative data in the United
States have demonstrated VTE risk persisting up to 90 days after surgery.[3] One study reports
VTE rates of 1.1%, 1.5%, 0.4%, 0.2%, 0.2% and 0.1% for colorectal resection, small bowel
Table 5. Multiple logistic regression analysis for 90-daymortality for patients undergoing general surgical procedures between 1 April 1997 and
31 March 2012.
Dependent factor = 90-day mortality Odds ratio (95% CI) Signiﬁcance
Emergency surgery 5.13 (4.62–5.70) p<0.001
Male gender 1.07 (1.07–1.08) p<0.001
Age 0.92 (0.84–1.01) p = 0.094
BMI 0.99 (0.98–1.00) p = 0.003
Comorbidity 0.99 (0.99–1.00) p<0.001
Length of stay 2.48 (2.27–2.71) p<0.001
SURGICAL PROCEDURE
Haemorrhoidectomy Reference
Bariatric surgery 4.07 (1.42–11.65) p = 0.009
Inguinal hernia repair 1.22 (0.86–1.74) p = 0.269
Thyroid /parathyroid excision 3.20 (2.04–5.03) p<0.001
Cholecystectomy 1.47 (1.03–2.10) p = 0.041
Breast excision 1.78 (1.18–2.68) p = 0.006
Appendicectomy 0.84 (0.54–1.32) p = 0.454
Antireﬂux surgery 1.56 (0.75–3.24) p = 0.540
Colorectal resection 9.95 (7.00–14.14) p<0.001
Small bowel resection 10.63 (7.34–15.39) p<0.001
Hepatopancreatobiliary resection 10.93 (7.03–16.99) p<0.001
Esophagogastric resection 18.22 (12.23–27.15) p<0.001
CANCER STAGE
No cancer Reference
Cancer stage I 0.89 (0.71–1.13) p = 0.337
Cancer stage II 0.89 (0.75–1.06) p = 0.197
Cancer stage III 1.12 (0.94–1.32) p = 0.208
Cancer stage IV 1.99 (1.74–2.27) p<0.001
Cancer stage unknown 1.21 (1.02–1.44) p = 0.027
VTE TYPE
No VTE Reference
In-hospital VTE 2.07 (1.51–2.85) p<0.001
Post-discharge VTE 4.03 (2.95–5.51) p<0.001
BMI = body mass index
VTE = venous thromboembolism
doi:10.1371/journal.pone.0145759.t005
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resection, inguinal hernia repair, appendicectomy, laparoscopic cholecystectomy and thyroid/
parathyroid resection respectively, generally lower than in the current study. The proportion of
post-discharge VTE from these data range between 40–75%. Using prospectively collected
NSQIP data, 30-day VTE rates are reported to be 1.90%, 0.23%, 0.09% and 0.19% in colorectal
resection, breast excision, hernia repair and laparoscopic cholecystectomy respectively, similar
to our study.[2, 24–26] Post-discharge VTE only accounts for about a third of VTE in the
NSQIP database, because the follow-up is limited to 30 days.[1, 2] While the proportion of
DVT and PE is not reported from administrative data, NSQIP reveals that about two-thirds of
postoperative VTE is accounted for by DVT. The lower proportion of DVT in our study
reflects the difference in methods of follow-up. While in NSQIP, patients are actively contacted
during prospective follow-up to be questioned about symptoms of complications, our study
relies on patients to present to healthcare. Our finding suggests that PE is more likely to present
to healthcare than DVT. In linked database analysis, primary care data increased the detection
of DVT, which were captured less reliably in hospital administrative and death certificate data.
Implications for Policy and Future Direction
The identification of deaths related to post-discharge VTE reiterates the importance of throm-
boprophylaxis and early intervention in preventing harm from VTE.[32] Using the same data-
set, Sultan et al. recommended extended thromboprophylaxis in pregnant women discharged
from hospital.[10] Walker et al. also proposed that thromboprophylaxis beyond 28 days may
benefit patients with advanced colorectal cancer receiving multimodal treatment.[11] In the
year 2010, NICE introduced recommendations for extended thromboprophylaxis to 28 days
after surgery in patients undergoing major cancer resection. Our analysis reveals that other
procedures may also be associated with substantial post-discharge VTE risk. Some of these
patients may benefit from extended thromboprophylaxis in addition to thromboprophylaxis
during in-hospital stay. In addition to drives to shorten hospital stay, increasing complexity of
treatments and changing population demographics may be some of the factors contributing to
higher post-discharge VTE risk associated with general surgical procedures than previously
appreciated. Prospective studies and randomized trials remain as gold standards to evaluate
whether further refinement in policy could benefit some patient groups. Linked databases can
improve our knowledge at population level serving as a platform for economic analysis and
evaluation of safety. It would be important to consider both the impact on mortality and the
health costs of VTE incurred to surviving patients.[33]
Other adverse events may also be suited for measurement in primary care. This may widen
the scope of using these resources to monitor patient safety and healthcare performance. In light
of drives to transfer clinical skills and resources from hospitals to primary care, service providers
and commissioners should embrace the use of linked routine databases as a valuable way of eval-
uating process and outcome within integrated health systems.[34] Further work is necessary to
validate these resources through direct comparisons with other types of data. As the linkage of
healthcare databases increases, methods for coding and reporting of harm in multiple datasets
should be standardized. CPRD is generated from one of several software systems used in primary
care. As 98% of practices in the UK use electronic health records, achieving uniformity of pri-
mary care software systems and further population linkage with hospital records may allow for
these resources to be developed for the purposes of service evaluation and driving quality
improvements on a national scale. Furthermore, the identification of significant levels of post-
discharge harmmay be relevant to health systems with less integration of primary and secondary
care services. The presented findings highlight the need to bridge care and for hospitals to offer
support when patients return to the community for recuperation after surgery.
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Conclusion
A large proportion of postoperative VTE was detected in the primary care setting. Evaluation
of linked databases was a useful way of measuring postoperative VTE at population level.
These resources identified a significant association between post-discharge VTE and mortality
in general surgery.
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